Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance

Abstract

The induction of cell death is recognized as a potent strategy for cancer treatment. Apoptosis is an extensively studied form of cell death, and multiple anticancer drugs exert their therapeutic effects by inducing it. Nonetheless, apoptosis evasion is a hallmark of cancer, rendering cancer cells resistant to chemotherapy drugs. Consequently, there is a growing interest in exploring novel non-apoptotic forms of cell death, such as ferroptosis, necroptosis, pyroptosis, and paraptosis. Natural compounds with anticancer properties have garnered significant attention due to their advantages, including a reduced risk of drug resistance. Over the past two decades, numerous natural compounds have been discovered to exert anticancer and anti-resistance effects by triggering these four non-apoptotic cell death mechanisms. This review primarily focuses on these four non-apoptotic cell death mechanisms and their recent advancements in overcoming drug resistance in cancer treatment. Meanwhile, it highlights the role of natural compounds in effectively addressing cancer drug resistance through the induction of these forms of non-apoptotic cell death.

Keywords

Drug resistance / cancer therapy / natural compound / non-apoptotic cell death

References

[1] Ferlay J,Soerjomataram I.Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.Int J Cancer2019;144:1941-53

[2] Strasser A.Cell death in the origin and treatment of cancer.Mol Cell2020;78:1045-54

[3] Labi V.How cell death shapes cancer.Cell Death Dis2015;6:e1675 PMCID:PMC4385913

[4] Montopoli M,Froldi G.Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.Cell Prolif2009;42:195-206 PMCID:PMC6495462

[5] Liu SY,Lin L.Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line.Chemotherapy2010;56:101-7

[6] Hanahan D.The hallmarks of cancer.Cell2000;100:57-70

[7] Rajabi M.The role of angiogenesis in cancer treatment.Biomedicines2017;5:34 PMCID:PMC5489820

[8] Tossetta G.Metformin improves ovarian cancer sensitivity to paclitaxel and platinum-based drugs: a review of in vitro findings.Int J Mol Sci2022;23:12893 PMCID:PMC9654053

[9] Tossetta G,Montanari E,Goteri G.Role of NRF2 in ovarian cancer.Antioxidants2022;11:663 PMCID:PMC9027335

[10] Ghareghomi S,Arese M,Moosavi-Movahedi AA.Nrf2 modulation in breast cancer.Biomedicines2022;10:2668 PMCID:PMC9599257

[11] Katz L.Natural product discovery: past, present, and future.J Ind Microbiol Biotechnol2016;43:155-76

[12] Bauman KD,Moore BS.Genome mining methods to discover bioactive natural products.Nat Prod Rep2021;38:2100-29 PMCID:PMC8597713

[13] Wu S,He Y.A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds.Biomed Pharmacother2021;140:111741

[14] Oberlies NH.Camptothecin and taxol: historic achievements in natural products research.J Nat Prod2004;67:129-35

[15] Škubník J,Ruml T.Vincristine in combination therapy of cancer: emerging trends in clinics.Biology2021;10:849 PMCID:PMC8468923

[16] Dixon SJ,Lamprecht MR.Ferroptosis: an iron-dependent form of nonapoptotic cell death.Cell2012;149:1060-72 PMCID:PMC3367386

[17] Liang C,Yang M.Recent progress in ferroptosis inducers for cancer therapy.Adv Mater2019;31:e1904197

[18] Yang WS.Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.Chem Biol2008;15:234-45 PMCID:PMC2683762

[19] Wang L,Du T.ATF3 promotes erastin-induced ferroptosis by suppressing system Xc.Cell Death Differ2020;27:662-75 PMCID:PMC7206049

[20] Sui X,Liu S.RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer.Front Pharmacol2018;9:1371 PMCID:PMC6262051

[21] Yang WS,Welsch ME.Regulation of ferroptotic cancer cell death by GPX4.Cell2014;156:317-31 PMCID:PMC4076414

[22] Lin Z,Kang R,Tang D.Lipid metabolism in ferroptosis.Adv Biol2021;5:e2100396

[23] Ke K,Lu C.The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer.Front Oncol2022;12:916082 PMCID:PMC9413412

[24] Mao C,Zhang Y.DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.Nature2021;593:586-90 PMCID:PMC8895686

[25] Koppula P,Zhang Y.A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.Nat Commun2022;13:2206 PMCID:PMC9033817

[26] Yi J,Wu J,Jiang X.Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis.Proc Natl Acad Sci U S A2020;117:31189-97 PMCID:PMC7733797

[27] Xiang J,Du X.The role of Hippo pathway in ferroptosis.Front Oncol2022;12:1107505 PMCID:PMC9874674

[28] Ye F,Xie M.HMGB1 regulates erastin-induced ferroptosis via Ras-JNK/P38 signaling in HL-60/Nras^Q61L cells.Am J Cancer Res2019;9:730-9 PMCID:PMC6511643

[29] Mirzaei S,Gholami MH.Nrf2 signaling pathway in cisplatin chemotherapy: potential involvement in organ protection and chemoresistance.Pharmacol Res2021;167:105575

[30] Li Y,Xu X,Wu C.Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.Oncol Lett2020;19:323-33 PMCID:PMC6923844

[31] Liu Y.p53 in ferroptosis regulation: the new weapon for the old guardian.Cell Death Differ2022;29:895-910 PMCID:PMC9091200

[32] Zhou X,Chen W.Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.Pharmacol Res2021;164:105305

[33] Green YS,Fuja DG.ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma.Oncogene2022;41:4709-23 PMCID:PMC9568429

[34] Su X,Zhang J.HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.Cell Death Dis2022;13:861 PMCID:PMC9547873

[35] Zhu YJ,Wang HY.New knowledge of the mechanisms of sorafenib resistance in liver cancer.Acta Pharmacol Sin2017;38:614-22 PMCID:PMC5457690

[36] Huang W,Lu Y.ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma.Neoplasia2021;23:1227-39 PMCID:PMC8591347

[37] Wang Q,Xue Q.GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.Cell Death Dis2021;12:426 PMCID:PMC8087704

[38] Cui Z,Li S.Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism.J Pharmacol Sci2022;148:73-85

[39] Li H,Liu Y.Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer.Pharmacol Res2022;182:106306

[40] Song M,Liu K.Therapeutic strategies to overcome cisplatin resistance in ovarian cancer.Eur J Med Chem2022;232:114205

[41] Li M,Shang J.LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.Eur Rev Med Pharmacol Sci2019;23:4185-91

[42] Ni M,Zhu Z.Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe²⁺ accumulation.Phytomedicine2023;112:154701

[43] Yang Y,Xu W.Piperlongumine inhibits thioredoxin reductase 1 by targeting selenocysteine residues and sensitizes cancer cells to erastin.Antioxidants2022;11:710 PMCID:PMC9030593

[44] Zhang Y,Liu S.Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis.Toxicol Mech Methods2023;33:47-55

[45] Yang C,Liu M.Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.Phytomedicine2023;111:154668

[46] Lou JS,Huang ZH.Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.Phytomedicine2021;80:153370

[47] Santana-Codina N.The role of NCOA4-mediated ferritinophagy in health and disease.Pharmaceuticals2018;11:114 PMCID:PMC6316710

[48] Zhou L,Zhong W.Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells.Biochem Pharmacol2021;193:114813

[49] He C,Liu H.Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells.BMC Cancer2022;22:724 PMCID:PMC9250166

[50] Markowitsch SD,Lauckner J.Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis.Cancers2020;12:3150 PMCID:PMC7692972

[51] Degterev A,Boyce M.Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.Nat Chem Biol2005;1:112-9

[52] Liu C,Shen H,Sun Q.Necroptosis: a novel manner of cell death, associated with stroke (Review).Int J Mol Med2018;41:624-30

[53] Gong Y,Luo G.The role of necroptosis in cancer biology and therapy.Mol Cancer2019;18:100 PMCID:PMC6532150

[54] Liu S,Li T.The role of regulated programmed cell death in osteoarthritis: from pathogenesis to therapy.Int J Mol Sci2023;24:5364 PMCID:PMC10049357

[55] Chen J,Garssen J.Molecular insights into the mechanism of necroptosis: the necrosome as a potential therapeutic target.Cells2019;8:1486 PMCID:PMC6952807

[56] de Almagro MC, Vucic D. Necroptosis: pathway diversity and characteristics.Semin Cell Dev Biol2015;39:56-62

[57] Su Z,Xu Y,Yu Q.Apoptosis, autophagy, necroptosis, and cancer metastasis.Mol Cancer2015;14:48 PMCID:PMC4343053

[58] Najafov A,Mookhtiar AK.BRAF and AXL oncogenes drive RIPK3 expression loss in cancer.PLoS Biol2018;16:e2005756 PMCID:PMC6114281

[59] Ermine KA,Wang P,Zhang L.Abstract A015: targeting necroptosis and RIP3 in colorectal cancer to overcome chemotherapeutic resistance.Cancer Res2022;82:A015

[60] Wang Q,Zhang L.Epigenetic regulation of RIP3 suppresses necroptosis and increases resistance to chemotherapy in nonsmall cell lung cancer.Transl Oncol2020;13:372-82 PMCID:PMC6938879

[61] Sun W,Shen L.MLKL is a potential prognostic marker in gastric cancer.Oncol Lett2019;18:3830-6 PMCID:PMC6732949

[62] Liu X,Gao H.Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells.Biochem Pharmacol2020;171:113684

[63] Huang CY,Huang YC,Yu LC.Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells.Cell Death Dis2013;4:e622 PMCID:PMC3674358

[64] Cui J,Liu X.Inorganic selenium induces nonapoptotic programmed cell death in PC-3 prostate cancer cells associated with inhibition of glycolysis.J Agric Food Chem2019;67:10637-45

[65] Liu XD,Kong CC.Bufalin induces programmed necroptosis in triple-negative breast cancer drug-resistant cell lines through RIP1/ROS-mediated pathway.Chin J Integr Med2022;28:900-8

[66] Sethy C.5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition.Biomed Pharmacother2021;137:111285

[67] Su J,Zhang D.Synergistic effects of 5-fluorouracil and gambogenic acid on A549 cells: activation of cell death caused by apoptotic and necroptotic mechanisms via the ROS-mitochondria pathway.Biol Pharm Bull2014;37:1259-68

[68] Pan X,Hu W.Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS.J Clin Lab Anal2022;36:e24452 PMCID:PMC9169161

[69] Liu L,Ai G.Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.Biol Res2019;52:37 PMCID:PMC6637630

[70] Zheng W,Zhu XQ.Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death.Biomed Pharmacother2018;106:175-82

[71] Shao CS,Zhou S.Ganoderic acid T improves the radiosensitivity of HeLa cells via converting apoptosis to necroptosis.Toxicol Res2021;10:531-41 PMCID:PMC8201584

[72] Ganju A,Khan S,Chauhan SC.Nanoways to overcome docetaxel resistance in prostate cancer.Drug Resist Updat2014;17:13-23 PMCID:PMC4100480

[73] Guo F,Wang F.Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer.Cell Death Differ2020;27:1938-51 PMCID:PMC7244590

[74] Gan L,Xu H.Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling.Prostate2011;71:1158-66

[75] Song L,Li J.Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer.Clin Cancer Res2011;17:1839-49

[76] Markowitsch SD,Schupp P.Shikonin reduces growth of docetaxel-resistant prostate cancer cells mainly through necroptosis.Cancers2021;13:882 PMCID:PMC7923752

[77] Wang Y,Nan Y.PKM2 inhibitor shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis.Int J Biol Sci2018;14:1883-91 PMCID:PMC6231221

[78] Lu B,Ding Y.RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide.Cancer Lett2018;425:31-42

[79] Cookson BT.Pro-inflammatory programmed cell death.Trends Microbiol2001;9:113-4

[80] Jorgensen I.Pyroptotic cell death defends against intracellular pathogens.Immunol Rev2015;265:130-42 PMCID:PMC4400865

[81] Lin J,Cheng K.New insights into the mechanisms of pyroptosis and implications for diabetic kidney disease.Int J Mol Sci2020;21:7057 PMCID:PMC7583981

[82] Gong W,Ren J.Research progresses of molecular mechanism of pyroptosis and its related diseases.Immunobiology2020;225:151884

[83] Isazadeh M,Haghdoust F,Orzáez M.Split-luciferase complementary assay of NLRP3 PYD-PYD interaction indicates inflammasome formation during inflammation.Anal Biochem2022;638:114510

[84] Zhang KJ,Jiang SM.Pyroptosis: a new frontier in kidney diseases.Oxid Med Cell Longev2021;2021:6686617 PMCID:PMC8102120

[85] Yu P,Liu N,Peng C.Pyroptosis: mechanisms and diseases.Signal Transduct Target Ther2021;6:128 PMCID:PMC8005494

[86] Ding J,Liu W.Pore-forming activity and structural autoinhibition of the gasdermin family.Nature2016;535:111-6

[87] Sarhan J,Muendlein HI.Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection.Proc Natl Acad Sci U S A2018;115:E10888-97 PMCID:PMC6243247

[88] Kovacs SB.Gasdermins: effectors of pyroptosis.Trends Cell Biol2017;27:673-84 PMCID:PMC5565696

[89] Zhang JY,Sun RY.The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8.Cell Res2021;31:980-97 PMCID:PMC8410789

[90] Matikainen S,Cypryk W.Function and regulation of noncanonical caspase-4/5/11 inflammasome.J Immunol2020;204:3063-9

[91] Li L,Bai Y.Role of GSDMB in pyroptosis and cancer.Cancer Manag Res2020;12:3033-43 PMCID:PMC7201009

[92] Deng W,Deng F.Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis.Nature2022;602:496-502 PMCID:PMC9703647

[93] Shi F,Liu X.Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death.Bioengineered2021;12:6332-42 PMCID:PMC8806686

[94] Chen D,Tang X.Combination of ruthenium (II) polypyridyl complex Δ-Ru1 and Taxol enhances the anti-cancer effect on Taxol-resistant cancer cells through Caspase-1/GSDMD-mediated pyroptosis.J Inorg Biochem2022;230:111749

[95] Li RY,Li ZM.Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer.Chem Biol Interact2022;361:109967

[96] Hou J,Xia W.PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis.Nat Cell Biol2020;22:1264-75 PMCID:PMC7653546

[97] Jiang H,Guo Y,Jiang Y.Wedelolactone induces apoptosis and pyroptosis in retinoblastoma through promoting ROS generation.Int Immunopharmacol2022;111:108855

[98] Cheng Z,Gu L.Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis.J Cancer2022;13:715-27 PMCID:PMC8771518

[99] Chen J,Niu Z,Kang C.Betulinic acid enhanced the chemical sensitivity of esophageal cancer cells to cisplatin by inducing cell pyroptosis and reducing cell stemness.Ann Palliat Med2020;9:1912-20

[100] Liang WF,Li HF.Curcumin activates ROS signaling to promote pyroptosis in hepatocellular carcinoma HepG2 cells.In Vivo2021;35:249-57 PMCID:PMC7880758

[101] Li Y,Li A.Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells.Chem Biol Interact2021;340:109434

[102] Sun X,Ma W.Germacrone induces caspase-3/GSDME activation and enhances ROS production, causing HepG2 pyroptosis.Exp Ther Med2022;24:456 PMCID:PMC9204551

[103] Hu Y,Cai Y.Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.Phytomedicine2023;108:154528

[104] Li F,Ren L.GSDME increases chemotherapeutic drug sensitivity by inducing pyroptosis in retinoblastoma cells.Oxid Med Cell Longev2022;2022:2371807 PMCID:PMC9035765

[105] Wang Y,Li D,Han X.GSDME mediates caspase-3-dependent pyroptosis in gastric cancer.Biochem Biophys Res Commun2018;495:1418-25

[106] Li C,Xue Y.Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC).Cell Biosci2021;11:38 PMCID:PMC7881658

[107] Sperandio S,Bredesen DE.An alternative, nonapoptotic form of programmed cell death.Proc Natl Acad Sci U S A2000;97:14376-81 PMCID:PMC18926

[108] Wang Y,Zhang N.Small-molecule compounds target paraptosis to improve cancer therapy.Biomed Pharmacother2019;118:109203

[109] Wang WB,Yue QX.Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90.J Cell Physiol2012;227:2196-206

[110] Sang J,Diao HJ.Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.Cancer Lett2021;509:13-25

[111] Yoon MJ,Jeong SA.Release of Ca²⁺ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells.Oncotarget2014;5:6816-31 PMCID:PMC4196165

[112] Lee HJ,Seo MJ,Kwon SK.PSMD14 targeting triggers paraptosis in breast cancer cells by inducing proteasome inhibition and Ca²⁺ imbalance.Int J Mol Sci2022;23:2648 PMCID:PMC8910635

[113] Hoa N,Douglass TG.Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine.PLoS One2009;4:e4631 PMCID:PMC2645013

[114] Kim IY,Lee DM.Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death.Biochem Pharmacol2019;162:41-54

[115] Man S,Cui J.Paris saponin II-induced paraptosis-associated cell death increased the sensitivity of cisplatin.Toxicol Appl Pharmacol2020;406:115206

[116] Zhang SR,Liang JF.Chalcomoracin inhibits cell proliferation and increases sensitivity to radiotherapy in human non-small cell lung cancer cells via inducing endoplasmic reticulum stress-mediated paraptosis.Acta Pharmacol Sin2020;41:825-34 PMCID:PMC7470873

[117] Li GN,Wang Z.Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation.Signal Transduct Target Ther2022;7:317 PMCID:PMC9468165

[118] Yoon MJ,Kwon TK,Choi KS.Simultaneous mitochondrial Ca²⁺ overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells.Cancer Lett2012;324:197-209

[119] Xue J,Zhao X.Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer.Chem Biol Interact2018;283:59-74

[120] Bury M,Mégalizzi V.Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity.Cell Death Dis2013;4:e561 PMCID:PMC3615734

[121] Binoy A,Katiyar N.Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function.Chem Biol Interact2019;310:108733

[122] Li B,Wang CZ.Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53.Cancer Lett2011;301:185-92 PMCID:PMC3022099

[123] Malireddi RKS,Kanneganti TD.ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis).Front Cell Infect Microbiol2019;9:406 PMCID:PMC6902032

[124] Wang Y,Haince JF.Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).Sci Signal2011;4:ra20 PMCID:PMC3086524

[125] Zheng P,Ding Y.Disulfidptosis: a new target for metabolic cancer therapy.J Exp Clin Cancer Res2023;42:103 PMCID:PMC10134647

[126] Tang D,Kroemer G.Cuproptosis: a copper-triggered modality of mitochondrial cell death.Cell Res2022;32:417-8 PMCID:PMC9061796

[127] Han N,Xie ZX.Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.Phytomedicine2023;112:154682

[128] Yuan B,Shi ZZ.Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/SLC7A11 axis.Onco Targets Ther2020;13:10829-40 PMCID:PMC7602909

[129] Chen Y,Zhang X.Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.J Exp Clin Cancer Res2019;38:402 PMCID:PMC6743121

[130] Yamaguchi Y,Kumakura S.Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis.Int J Oncol2018;52:1011-22

[131] Sang J,Zou MF.Jolkinolide B sensitizes bladder cancer to mTOR inhibitors via dual inhibition of Akt signaling and autophagy.Cancer Lett2022;526:352-62